Its quite incredible how little analysts and commentators know about things they talk about!
- Forums
- ASX - By Stock
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
1.38%
!
$2.21

Its quite incredible how little analysts and commentators know...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.21 |
Change
0.030(1.38%) |
Mkt cap ! $700.5M |
Open | High | Low | Value | Volume |
$2.18 | $2.22 | $2.18 | $635.0K | 289.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 7933 | $2.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.21 | 2419 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 7933 | 2.200 |
10 | 25480 | 2.190 |
11 | 39490 | 2.180 |
9 | 29811 | 2.170 |
8 | 21794 | 2.160 |
Price($) | Vol. | No. |
---|---|---|
2.220 | 6785 | 6 |
2.230 | 32048 | 9 |
2.240 | 57358 | 11 |
2.250 | 72171 | 10 |
2.260 | 14621 | 3 |
Last trade - 10.16am 19/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online